Tag: Enanta Pharmaceuticals Inc.

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Forecasted to Earn Q2 2021 Earnings of ($1.07 ...

Added to Collection on: 2021-02-10 13:52:30

Tags for this article:

Finance
Money
Financial markets
Investment
Valuation
Fundamental analysis
Corporate finance
Stock market
Price?earnings ratio
Stock
Growth investing
Value investing
Enanta Pharmaceuticals Inc.
S&P 500 INDEX - CBOE

Click the tags to see associated articles and topics

View Article Details
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Consensus Rating of "Hold" by Analysts

Added to Collection on: 2021-02-25 12:11:15

Tags for this article:

Finance
Money
Economy
Valuation
Corporate finance
Stock
Short
Securities research
Financial analyst
Price?earnings ratio
Enanta Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
Brokerages Expect Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Will Post Quarterly Sales of ...

Added to Collection on: 2021-03-06 07:00:23

Tags for this article:

Finance
Financial markets
Money
Corporate finance
Stock
Stock market
Price?earnings ratio
Short
Enanta Pharmaceuticals Inc.
Zacks

Click the tags to see associated articles and topics

View Article Details
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D ...

Added to Collection on: 2021-10-07 12:22:30

Tags for this article:

Life Sciences
Companies
Biotechnology companies
Economy of New York City
NASDAQ
Amgen
MorphoSys
Vertex Pharmaceuticals
Pluristem Therapeutics
PTC Therapeutics
ensysce biosciences, inc.
DURECT Corporation
Indaptus Therapeutics Inc.
Aziyo Biologics Inc.
eiger biopharmaceuticals inc
Minerva Neurosciences Inc
Aytu BioPharma Inc.
Orphazyme A/S
ROCKWELL MEDICAL , INC
Glaukos Corporation
Heron Therapeutics Inc
Longeveron Inc.
HCW Biologics Inc.
Catalyst Pharmaceuticals Inc
Hoth Therapeutics Inc.
DICE Therapeutics, Inc.
TELIGENT , INC
Aptinyx Inc.
Nuwellis Inc.
Adverum Biotechnologies Inc.
BiondVax Pharmaceuticals Ltd.
Spruce Biosciences Inc.
Mesoblast Limited
Chemomab Therapeutics, Ltd.
Kiniksa Pharmaceuticals Ltd
trevi therapeutics, inc.
Black Diamond Therapeutics, Inc.
Avenue Therapeutics Inc.
China SXT Pharmaceuticals Inc.
Amgen Inc.
POINT Biopharma Global Inc.
TCR2 Therapeutics Inc.
Pluristem Therapeutics Inc.
Forte Biosciences Inc.
Vertex Pharmaceuticals Incorporated
Oncorus Inc.
Year Moderna, Inc.
Acutus Medical Inc.
Neovasc Inc.
Spectrum Pharmaceuticals Inc.
Oyster Point Pharma Inc.
Incyte Corporation
Moleculin Biotech Inc.
Nautilus Biotechnology Inc.
Caladrius Biosciences Inc.
MORPHOSYS AG
Inhibikase Therapeutics Inc.
Galecto Inc.
MaxCyte Inc.
Immunic Inc
Kiromic BioPharma Inc.
Cellectis SA
Gamida Cell Ltd
BioSig Technologies Inc.
LumiraDx Limited
NRx Pharmaceuticals, Inc.
Stoke Therapeutics Inc
histogen inc
Calliditas Therapeutics AB
PTC Therapeutics Inc.
Solid Biosciences Inc.
Aravive Inc
Titan Pharmaceuticals Inc.
Roivant Sciences Ltd.
Liminal BioSciences Inc.
Akoya Biosciences Inc.
Kaleido Biosciences Inc.
Applied Genetic Technologies Corporation
Moderna
Assertio Holdings Inc.
Talis Biomedical Corporation
Sangamo Therapeutics Inc.
Lixte Biotechnology Holdings Inc.
Petros Pharmaceuticals Inc.
KALA PHARMACEUTICALS, INC
XBiotech Inc.
Orchard Therapeutics plc
Legend Biotech Corporation
Galapagos NV
Angion Biomedica Corp
Applied Dna Sciences Inc.
Esperion Therapeutics Inc.
Imara Inc.
Enanta Pharmaceuticals Inc.
Harpoon Therapeutics Inc.
Graphite Bio Inc.
Tiziana Life Sciences PLC
BioVie Inc
Applied Molecular Transport Inc.
Viveve Medical Inc.
Immuron Limited
Protara Therapeutics Inc.
4d molecular therapeutics
HOOKIPA Pharma Inc.
Pasithea Therapeutics Corp.
CASI PHARMACEUTICALS , INC
InMed Pharmaceuticals Inc.
Gain Therapeutics Inc.
NeuroBo Pharmaceuticals Inc.
Opiant Pharmaceuticals Inc
Lipocine Inc

Click the tags to see associated articles and topics

View Article Details
Pfizer's Covid Antiviral Paxlovid Target of Enanta Patent Suit - Bloomberg Law

Added to Collection on: 2022-06-22 16:52:26

Tags for this article:

Life Sciences
3C-like protease
Protease inhibitor
Pfizer
Antiviral drugs
Virology
Medical specialties
Pfizer Inc.
Enanta Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
'Keep developing your expertise' - American Society for Biochemistry and Molecular Biology

Added to Collection on: 2022-09-16 10:58:48

Tags for this article:

Health sciences
Pharmaceutical industry
Pharmacology
Pharmacy
Articles
Biochemist
Virus
Health
Enanta Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
Oregon Public Employees Retirement Fund Sells 676 Shares of Enanta Pharmaceuticals ...

Added to Collection on: 2022-10-22 09:19:45

Tags for this article:

Life Sciences
Economy
Financial markets
Abbott Laboratories
Lake Bluff, Illinois
Stock
Short
NASDAQ Biotechnology Index
Enanta Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
Oregon Public Employees Retirement Fund Sells 676 Shares of Enanta ... - The AM Reporter

Added to Collection on: 2022-10-22 08:46:58

Tags for this article:

Life Sciences
Articles
Health
Abbott Laboratories
Lake Bluff, Illinois
Pharmaceutical industry in China
Short
Enanta Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
'More severe' flu season expected this winter - Yahoo News

Added to Collection on: 2022-11-08 22:21:41

Tags for this article:

Protease inhibitor
Antiviral drug
Chemistry
Enanta Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
HC Wainwright has added Enanta Pharmaceuticals (NASDAQ:ENTA) to its coverage list.

Added to Collection on: 2022-12-10 18:52:42

Tags for this article:

Economy
Life Sciences
Financial markets
Abbott Laboratories
Lake Bluff, Illinois
Stock
Short
Enanta Pharmaceuticals Company
Enanta Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details